Clinical Trial Update: A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 fixed-dose, dose‑response study of ropinirole prolonged release in patients with early-stage Park…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole prolonged-release (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-02-02